Large, drooping breasts are the hardest case for an implant reconstruction done at the same time as a mastectomy. There is too much skin, and the nipple sits too low. Skin-reducing mastectomy deals with both in one operation. This article explains how it works, what the published results show, and which patients it suits.

In short

How it works

Nava and colleagues in Milan described the operation in 2006, for breasts with more than 8 cm between the areola and the fold under the breast.1

The operation in four steps
One operation removes the breast tissue, reduces the skin and rebuilds the breast. The patient’s own skin protects the implant from below.Technique as described by Nava 2006.

The kept layer of skin is called the dermal flap. It is living tissue with its own blood supply. If the scar above it opens, the implant is still covered.

Two layers over the lower pole
The dermal flap is the patient's own vascularised tissue, used where the closure is weakest. The upper pole is covered by muscle or by a matrix, depending on the plane.Schematic, not to scale. Technique as described by Nava 2006 and later modifications reviewed by Hansson 2018.

The top of the implant can be covered by the chest muscle, or by a matrix when the implant sits on top of the muscle. Surgeons have published many versions. A 2018 review counted nine families of them.7

What the studies found

The first report was honest about the risks. In 30 procedures, 4 reconstructions (13%) lost skin badly enough that the implant had to be removed.1

Later reports did better. Colizzi and colleagues in Pisa changed how the flap is attached, in 22 procedures.2 Bonomi and colleagues in Milan reported 62 procedures with a dermal flap and an absorbable mesh. Results were good to excellent in 92.8%, and 84% of patients were very or highly satisfied. Higher body mass index was the strongest risk factor for complications.3

In a 2025 series of 20 patients with no mesh or matrix, slow healing at the T-junction was the most common problem, and no implant was lost.4 Patients expected to need radiotherapy were not included.

What the published series reported
Results improved after the first report, as surgeons refined the technique and chose patients more carefully. The bars show different measures and cannot be compared directly.Nava 2006; Bonomi 2019; Abdelmageed 2025; Varvaras 2023 (congress poster, not peer-reviewed); Riccio 2026.

With a bovine pericardium matrix

Two sources describe the operation with ExaShape®. A 2023 congress poster reported 30 breasts with a mean mastectomy weight of 985 g. Five breasts (16.6%) had a complication and no implant was removed.5 A poster has not been through peer review.

In the Riccio 2026 study, all 56 patients had the anchor-shaped cuts and 78.5% had ExaShape. 94.6% of implants were kept.6 The paper reports results for the whole group, not by matrix.

Who it suits

Who is a good candidate
The patient matters more than the implant size. Body mass index was the strongest risk factor in the largest series.Nava 2006; Bonomi 2019; Varvaras 2023 (poster); Abdelmageed 2025.

For patients at higher risk, a two-stage reconstruction may be safer. See mastectomy flap necrosis: risk assessment and radiotherapy and implant reconstruction.

There is also an alternative that avoids the anchor-shaped cuts. A 2025 series of 62 patients with breasts up to 799 g kept the skin and placed the implant on top of the muscle. 37% had rippling or a small contour problem, and 29% had fat grafting.8

Most of these patients also need the other breast reduced or lifted. Doing that in the same operation did not raise complications in a 2025 pooled analysis, although most of those patients had reconstruction with their own tissue.9

What it means in practice

Skin-reducing mastectomy does not suit everyone with large breasts. In a well-chosen patient, it removes the cancer, reduces the skin and rebuilds the breast in one operation, with her own skin protecting the implant where it is most exposed.

References

  1. Nava MB, Cortinovis U, Ottolenghi J, et al. Skin-reducing mastectomy. Plast Reconstr Surg. 2006;118(3):603-610. doi:10.1097/01.prs.0000233024.08392.14
  2. Colizzi L, Lazzeri D, Agostini T, et al. Skin-reducing mastectomy: new refinements. J Plast Surg Hand Surg. 2010;44(6):296-301. doi:10.3109/2000656X.2010.517681
  3. Bonomi S, Sala L, Gennaro M, Ricci C, Cortinovis U. Skin-reducing mastectomy and direct-to-implant breast reconstruction with submuscular-dermal-mesh pocket. Ann Plast Surg. 2019;82(1):19-27. doi:10.1097/SAP.0000000000001614
  4. Abdelmageed AE, Awad AT, El-Fayoumi TA, et al. Skin-reducing mastectomy and direct-to-implant breast reconstruction without mesh: a single-institute experience. Cureus. 2025;17(3):e81417. doi:10.7759/cureus.81417
  5. Varvaras D, Sachoulidou A, De Felice V, et al. Skin-reducing mastectomy and immediate hybrid breast reconstruction using acellular pericardium matrix and de-epithelialized dermal flap in medium and large hypertrophic and ptotic breasts. Poster, St. Gallen International Breast Cancer Conference; 2023.
  6. Riccio M, Zingaretti N, Aquinati A, et al. Oncoaesthetic breast reconstruction after mastectomy improves patient satisfaction and aesthetic outcomes. Clin Breast Cancer. 2026;26(10):134-146. doi:10.1016/j.clbc.2026.08.025
  7. Hansson E, Jepsen C, Hallberg H. Breast reconstruction with a dermal sling: a systematic review of surgical modifications. J Plast Surg Hand Surg. 2019;53(1):1-13. doi:10.1080/2000656X.2018.1533840
  8. Salgarello M, Fabbri M, Visconti G, et al. Immediate breast reconstruction with prepectoral polyurethane-covered implant after conservative mastectomy in large and ptotic breasts. Aesthetic Plast Surg. 2025;49(23):6555-6564. doi:10.1007/s00266-025-05070-w
  9. Wang CY, Montalmant KE, Peng T, et al. The safety of simultaneous versus delayed contralateral breast symmetrization: systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2025;105:348-358. doi:10.1016/j.bjps.2025.04.023